Recruiting studies: Latent Tuberculosis Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688 The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in
Phase 4 · 1 location(s) · National Taiwan University Hospital · NCT05588492 ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
Phase N/A · 2 location(s) · Chinese University of Hong Kong · NCT06796647 Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742 Training Protocol on the Natural History of Tuberculosis
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01212003 Testing Health Workers At Risk to Advance Our Understanding of TB Infection
Phase N/A · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06221488 Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06485895 Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
Phase N/A · 17 location(s) · Meyer Children's Hospital IRCCS · NCT06289660 Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
NA · 13 location(s) · Pontificia Universidad Catolica de Chile · NCT07086820 Effects of Tuberculosis Infection on Development and Function of the Placenta
Phase N/A · 1 location(s) · Lund University · NCT06352970 Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764576 Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active
Phase N/A · 3 location(s) · University of Stellenbosch · NCT04700579 Diagnosis of Tuberculosis in Swiss Children
Phase N/A · 8 location(s) · University Children's Hospital Basel · NCT03044509 Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Phase 2/Phase 3 · 6 location(s) · Johns Hopkins University · NCT06568484 Immunological Biomarkers in Tuberculosis Management
NA · 1 location(s) · Hospices Civils de Lyon · NCT04271397 Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
Phase N/A · 1 location(s) · Eleonora Nucera · NCT05756582 Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Phase 2/Phase 3 · 21 location(s) · Centers for Disease Control and Prevention · NCT03474029 A Systemic Screening for TB Disease in High-risk Groups in Barcelona
Phase N/A · 1 location(s) · Fundació Institut Germans Trias i Pujol · NCT06706596 The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
Phase N/A · 2 location(s) · Linkoeping University · NCT06580639 Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Phase N/A · 3 location(s) · University of Oxford · NCT06526689 A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among
Phase 3 · 66 location(s) · Huashan Hospital · NCT06022146 PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
Phase N/A · 1 location(s) · University College, London · NCT07024836 Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT06281834 Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Phase N/A · 44 location(s) · Huashan Hospital · NCT06033807 Shorter and Safer Treatment Regimens for Latent TB
Phase 2/Phase 3 · 14 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06498414 Economic Incentives and vDOT for Latent Tuberculosis Infection
NA · 1 location(s) · Johns Hopkins University · NCT05022862

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.